Takeda and Dr. Reddy's Laboratories enter into exclusive collaboration to promote and distribute QDENGA in India's pediatric and adult private market

Mumbai (Maharashtra) [India], September 18 (ANI): Takeda Pharmaceutical Company Limited, through its Indian subsidiary Takeda Biopharmaceuticals India Private Limited (together referred to as "Takeda") and Dr Reddy's Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY, along with its subsidiaries together referred to as "Dr Reddy's") today entered into a distribution agreement under which Dr Reddy